📋 FDA Reference

The Philips MP20 MP30 MP40 MP50 MP60 MP70 MP80 and MP90 Intellivue Atient Monitors

Philips Medizin Systeme Boblingen

Compare similar devices

Summary: The Philips IntelliVue patient monitors (MP20 to MP90) are advanced monitoring systems used in hospitals to track vital signs and other critical patient data. They are primarily used by healthcare professionals in intensive care units and other critical care settings.

FDA Clearance Information

Pathway ? 510(k)
Number ? K060541 ↗
Decision Date ? March 24, 2006
Product Code ? MHX
Device Class ? Class 2
Evidence ? 419 studies

The Philips IntelliVue patient monitors were cleared through the FDA 510(k) pathway on March 24, 2006. Manufactured by Philips Medizin Systeme Boblingen, these devices are classified as Class 2 under product code MHX.

What It Is

The Philips IntelliVue patient monitors are a series of advanced medical devices designed to provide continuous monitoring of vital signs such as heart rate, blood pressure, and oxygen saturation. These monitors are equipped with high-resolution displays and customizable interfaces, allowing clinicians to tailor the monitoring experience to specific patient needs. They are designed to integrate with hospital information systems, providing seamless data transfer and enhancing clinical decision-making.

FDA-Cleared Indications

  • Monitoring physiological parameters in patients who require clinical observation.
  • Displaying, recording, and analyzing measured patient data using compatible sensors, transducers, and accessories.
  • Use by trained healthcare professionals in healthcare settings according to the monitor configuration and applicable labeling.

Clinical Applications

  • Continuous bedside monitoring of vital signs in hospitalized patients.
  • Monitoring patients in critical care and other areas where close observation is required.
  • Physiological monitoring during anesthesia, surgery, and recovery when configured with the necessary parameters.
  • Monitoring patients in emergency and acute-care settings.
  • Displaying measurements such as heart rate, blood pressure, and oxygen saturation when the appropriate modules and sensors are connected.

Practical Considerations

  • The MP20 through MP90 models have different screen sizes, parameter capacity, connectivity, and mobility features; the exact configuration should be verified before use.
  • Measurements depend on compatible, correctly applied sensors, cables, cuffs, transducers, and modules. Follow the monitor and accessory labeling for patient size and parameter-specific use.
  • These monitors are not automatically MRI safe. Confirm the exact model, installed components, and facility MRI policy before bringing any monitor or accessory into an MRI environment.
  • The monitor is intended for use by trained healthcare professionals and does not replace clinical assessment or alarm-response protocols.
  • Routine electrical safety checks, cleaning, calibration, software maintenance, and accessory inspection are required according to the manufacturer's instructions and institutional policy.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Philips IntelliVue patient monitor used for?

It is used for continuous monitoring of vital signs in critically ill patients in settings like ICUs and operating rooms.

What specialties typically use this device?

Specialties such as cardiology, anesthesiology, and emergency medicine commonly use these monitors.

What are the FDA-cleared indications?

The monitors are indicated for continuous monitoring of vital signs in patients who require close observation, such as those in critical care settings.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you